Metraipolis › archive › dc_d2eeadaae9d9
Antineoplastic Activity of the Combination Loratadine-Simvastatin-Gefitinib in HPV-Positive Cervical Cancer Cells: In Vitro and In Vivo Studies — Europe PMC PMID:42649903
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42649903
- DOI
- 10.3390/cancers18162589
- License (as archived)
- solo-consultazione
- Archived
- 2026-10-16T20:51:15.546Z
- SHA-256 of the archived text
608b9b2b88a4e715651f0f13ee44564043e5cc051f0a79f4e01e184df77edc96- Stable URL of this page
https://metraipolis.com/documento/dc_d2eeadaae9d9
How to cite
Antineoplastic Activity of the Combination Loratadine-Simvastatin-Gefitinib in HPV-Positive Cervical Cancer Cells: In Vitro and In Vivo Studies — Europe PMC PMID:42649903 — Europe PMC (en), https://europepmc.org/article/MED/42649903 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_d2eeadaae9d9 (Metraipolis archive dc_d2eeadaae9d9, sha256 608b9b2b88a4e715651f0f13ee44564043e5cc051f0a79f4e01e184df77edc96)
BibTeX
@misc{dcd2eeadaae9d9,
title = {Antineoplastic Activity of the Combination Loratadine-Simvastatin-Gefitinib in HPV-Positive Cervical Cancer Cells: In Vitro and In Vivo Studies — Europe PMC PMID:42649903},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42649903},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_d2eeadaae9d9; sha256 608b9b2b88a4e715651f0f13ee44564043e5cc051f0a79f4e01e184df77edc96},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42649903. Agents can read the archived copy with the MCP tool read_document.